216 related articles for article (PubMed ID: 23262930)
1. Association of abnormal ovarian reserve parameters with a higher incidence of aneuploid blastocysts.
Katz-Jaffe MG; Surrey ES; Minjarez DA; Gustofson RL; Stevens JM; Schoolcraft WB
Obstet Gynecol; 2013 Jan; 121(1):71-7. PubMed ID: 23262930
[TBL] [Abstract][Full Text] [Related]
2. Higher rates of aneuploidy in blastocysts and higher risk of no embryo transfer in recurrent pregnancy loss patients with diminished ovarian reserve undergoing in vitro fertilization.
Shahine LK; Marshall L; Lamb JD; Hickok LR
Fertil Steril; 2016 Oct; 106(5):1124-1128. PubMed ID: 27371114
[TBL] [Abstract][Full Text] [Related]
3. Maternal serum concentration of anti-Müllerian hormone is a better predictor than basal follicle stimulating hormone of successful blastocysts development during IVF treatment.
Sadruddin S; Barnett B; Ku L; Havemann D; Mucowski S; Herrington R; Burggren W
PLoS One; 2020; 15(10):e0239779. PubMed ID: 33044971
[TBL] [Abstract][Full Text] [Related]
4. Maternal and Neonatal Complications in Patients With Diminished Ovarian Reserve in
Han S; Zhai Y; Guo Q; Qin Y; Liu P
Front Endocrinol (Lausanne); 2021; 12():648287. PubMed ID: 33995280
[TBL] [Abstract][Full Text] [Related]
5. Female age, serum antimüllerian hormone level, and number of oocytes affect the rate and number of euploid blastocysts in in vitro fertilization/intracytoplasmic sperm injection cycles.
La Marca A; Minasi MG; Sighinolfi G; Greco P; Argento C; Grisendi V; Fiorentino F; Greco E
Fertil Steril; 2017 Nov; 108(5):777-783.e2. PubMed ID: 28987789
[TBL] [Abstract][Full Text] [Related]
6. Follicular versus luteal phase ovarian stimulation during the same menstrual cycle (DuoStim) in a reduced ovarian reserve population results in a similar euploid blastocyst formation rate: new insight in ovarian reserve exploitation.
Ubaldi FM; Capalbo A; Vaiarelli A; Cimadomo D; Colamaria S; Alviggi C; Trabucco E; Venturella R; Vajta G; Rienzi L
Fertil Steril; 2016 Jun; 105(6):1488-1495.e1. PubMed ID: 27020168
[TBL] [Abstract][Full Text] [Related]
7. Correlation between aneuploidy, standard morphology evaluation and morphokinetic development in 1730 biopsied blastocysts: a consecutive case series study.
Minasi MG; Colasante A; Riccio T; Ruberti A; Casciani V; Scarselli F; Spinella F; Fiorentino F; Varricchio MT; Greco E
Hum Reprod; 2016 Oct; 31(10):2245-54. PubMed ID: 27591227
[TBL] [Abstract][Full Text] [Related]
8. A diagnosis of diminished ovarian reserve does not impact embryo aneuploidy or live birth rates compared to patients with normal ovarian reserve.
Fouks Y; Penzias A; Neuhausser W; Vaughan D; Sakkas D
Fertil Steril; 2022 Sep; 118(3):504-512. PubMed ID: 35820943
[TBL] [Abstract][Full Text] [Related]
9. Diminished ovarian reserve as measured by means of baseline follicle-stimulating hormone and antral follicle count is not associated with pregnancy loss in younger in vitro fertilization patients.
Bishop LA; Richter KS; Patounakis G; Andriani L; Moon K; Devine K
Fertil Steril; 2017 Dec; 108(6):980-987. PubMed ID: 29202975
[TBL] [Abstract][Full Text] [Related]
10. Association Between Biomarkers of Ovarian Reserve and Infertility Among Older Women of Reproductive Age.
Steiner AZ; Pritchard D; Stanczyk FZ; Kesner JS; Meadows JW; Herring AH; Baird DD
JAMA; 2017 Oct; 318(14):1367-1376. PubMed ID: 29049585
[TBL] [Abstract][Full Text] [Related]
11. Correlation between standard blastocyst morphology, euploidy and implantation: an observational study in two centers involving 956 screened blastocysts.
Capalbo A; Rienzi L; Cimadomo D; Maggiulli R; Elliott T; Wright G; Nagy ZP; Ubaldi FM
Hum Reprod; 2014 Jun; 29(6):1173-81. PubMed ID: 24578475
[TBL] [Abstract][Full Text] [Related]
12. A prospective study on role of dehydroepiandrosterone (DHEA) on improving the ovarian reserve markers in infertile patients with poor ovarian reserve.
Singh N; Zangmo R; Kumar S; Roy KK; Sharma JB; Malhotra N; Vanamail P
Gynecol Endocrinol; 2013 Nov; 29(11):989-92. PubMed ID: 24004296
[TBL] [Abstract][Full Text] [Related]
13. [Effects of cystectomy for ovary benign cyst on ovarian reserve and pregnancy outcome of in vitro fertilization-embryo transfer cycle].
Zhang XR; Ding LL; Tang R; Sheng Y; Qin YY; Chen ZJ
Zhonghua Fu Chan Ke Za Zhi; 2016 Mar; 51(3):180-5. PubMed ID: 27030496
[TBL] [Abstract][Full Text] [Related]
14. Genetic diseases and aneuploidies can be detected with a single blastocyst biopsy: a successful clinical approach.
Minasi MG; Fiorentino F; Ruberti A; Biricik A; Cursio E; Cotroneo E; Varricchio MT; Surdo M; Spinella F; Greco E
Hum Reprod; 2017 Aug; 32(8):1770-1777. PubMed ID: 28633287
[TBL] [Abstract][Full Text] [Related]
15. Dehydroepiandrosterone plus climen supplementation shows better effects than dehydroepiandrosterone alone on infertility patients with diminished ovarian reserve of low-FSH level undergoing in-vitro fertilization cycles: a randomized controlled trial.
Zhang H; Chu Y; Zhou P; He X; Xu Q; Zhang Z; Cao Y; Wei Z
Reprod Biol Endocrinol; 2016 Feb; 14():9. PubMed ID: 26879683
[TBL] [Abstract][Full Text] [Related]
16. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.
Kunt C; Ozaksit G; Keskin Kurt R; Cakir Gungor AN; Kanat-Pektas M; Kilic S; Dede A
Arch Gynecol Obstet; 2011 Jun; 283(6):1415-21. PubMed ID: 21562964
[TBL] [Abstract][Full Text] [Related]
17. Short-Term Impact of Laparoscopic Cystectomy on Ovarian Reserve Tests in Bilateral and Unilateral Endometriotic and Nonendometriotic Cysts.
Salihoğlu KN; Dilbaz B; Cırık DA; Ozelci R; Ozkaya E; Mollamahmutoğlu L
J Minim Invasive Gynecol; 2016; 23(5):719-25. PubMed ID: 26940401
[TBL] [Abstract][Full Text] [Related]
18. Correlation of antimüllerian hormone and baseline follicle-stimulating hormone levels.
Singer T; Barad DH; Weghofer A; Gleicher N
Fertil Steril; 2009 Jun; 91(6):2616-9. PubMed ID: 18555223
[TBL] [Abstract][Full Text] [Related]
19. Early follicular antimüllerian hormone as an indicator of ovarian reserve.
Fiçicioglu C; Kutlu T; Baglam E; Bakacak Z
Fertil Steril; 2006 Mar; 85(3):592-6. PubMed ID: 16500324
[TBL] [Abstract][Full Text] [Related]
20. Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients.
Arce JC; La Marca A; Mirner Klein B; Nyboe Andersen A; Fleming R
Fertil Steril; 2013 May; 99(6):1644-53. PubMed ID: 23394782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
